BR9908825A - Forma cristalina de paroxetina - Google Patents
Forma cristalina de paroxetinaInfo
- Publication number
- BR9908825A BR9908825A BR9908825-8A BR9908825A BR9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A
- Authority
- BR
- Brazil
- Prior art keywords
- paroxetine
- crystalline form
- free
- crystalline
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9908825A true BR9908825A (pt) | 2000-11-21 |
Family
ID=27269245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9908825-8A BR9908825A (pt) | 1998-03-16 | 1999-03-16 | Forma cristalina de paroxetina |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1064282A1 (hu) |
JP (1) | JP2002506865A (hu) |
KR (1) | KR20010041947A (hu) |
CN (1) | CN1300286A (hu) |
AP (1) | AP2000001907A0 (hu) |
AU (1) | AU2847199A (hu) |
BG (1) | BG104839A (hu) |
BR (1) | BR9908825A (hu) |
CA (1) | CA2323896A1 (hu) |
EA (1) | EA200000946A1 (hu) |
HU (1) | HUP0101215A3 (hu) |
ID (1) | ID27596A (hu) |
IL (1) | IL138390A0 (hu) |
NO (1) | NO20004583L (hu) |
PL (1) | PL342931A1 (hu) |
SK (1) | SK13622000A3 (hu) |
TR (1) | TR200002675T2 (hu) |
WO (1) | WO1999047519A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
US20080033050A1 (en) * | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
SK283608B6 (sk) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie |
-
1999
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SK13622000A3 (sk) | 2001-03-12 |
NO20004583L (no) | 2000-09-15 |
JP2002506865A (ja) | 2002-03-05 |
TR200002675T2 (tr) | 2000-12-21 |
AU2847199A (en) | 1999-10-11 |
CN1300286A (zh) | 2001-06-20 |
IL138390A0 (en) | 2001-10-31 |
NO20004583D0 (no) | 2000-09-14 |
HUP0101215A2 (hu) | 2002-04-29 |
HUP0101215A3 (en) | 2002-05-28 |
CA2323896A1 (en) | 1999-09-23 |
ID27596A (id) | 2001-04-12 |
EP1064282A1 (en) | 2001-01-03 |
BG104839A (en) | 2001-09-28 |
EA200000946A1 (ru) | 2001-02-26 |
WO1999047519A1 (en) | 1999-09-23 |
PL342931A1 (en) | 2001-07-16 |
AP2000001907A0 (en) | 2000-09-30 |
KR20010041947A (ko) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
BRPI0014076B8 (pt) | benzamidas e inibidores correlatos do fator xa | |
PT1143967E (pt) | Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas | |
BR0014384A (pt) | Compostos para o tratamento da isquémia | |
ATE331534T1 (de) | Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs | |
BR0014078A (pt) | Inibidores de fator xa | |
SE0101387D0 (sv) | Novel compounds | |
BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
PT777482E (pt) | Composicao de combinacao para utilizacao em doencas imunologicas | |
BR9912376A (pt) | Sais de nitrato, composições farmacêuticas, udo de sais e composições, e, processo para preparação de sais de nitrato. | |
SE9802208D0 (sv) | Novel compounds | |
BR0208353A (pt) | Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças | |
BR0115036A (pt) | Processo para a preparação de um composto | |
DE59813162D1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
PT1030667E (pt) | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono | |
BR0012169A (pt) | Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia | |
NO962655D0 (no) | Deutrerte virkestoffer i transdermal applikasjon | |
BR9908825A (pt) | Forma cristalina de paroxetina | |
TR200101693T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
ES2088877T3 (es) | Procedimiento de preparacion del 3-pirrolidinol. | |
PT1294732E (pt) | Compostos de rutenio (ii) para utilizacao na terapia do cancro | |
DK1152757T3 (da) | MMP-inhibitorer i bindevævsblödhed | |
AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |